12/19/2008

A committee with the European Medicines Agency recommended the addition of suicide warnings on labels of epilepsy drugs, including Pfizer's Lyrica and Eisai's Zonegran. The announcement comes days after the FDA said it is requiring similar warnings on some epilepsy treatments sold in the U.S.

Related Summaries